Alnylam announced the FDA approval of its supplemental new drug application for vutrisiran, an RNA interfering small molecule ...

The FDA has approved Tremfya as the “first and only” interleukin-23 inhibitor that offers both IV and fully subcutaneous ...

Cataracts are the leading cause of blindness in adults older than age 50 worldwide.The global prevalence of cataracts has ...

As cornea specialists, we talk a lot about how to get timely referrals of keratoconus patients from optometrists and ...

Technosphere insulin, a rapid-acting human insulin administrated through an inhaler, was associated with reductions in HbA1c ...

In primary care settings, the burden of RSV on young children and their guardians often varied between the countries of ...

The use of technicians to assist in delivering dialysis to the end-stage kidney disease population has been a recognized role ...

The addition of concurrent cisplatin to adjuvant radiation therapy conferred no benefit to women with intermediate-risk, ...

Madness in men’s and women’s college basketball kicks off, millions will tune in to watch and bet — with the latter having ...

A long time ago, my kids taught me that the importance of pain depends upon whether you are the one giving it or the one ...

Individuals in Canada who received hospital care for hallucinogen use had greater 5-year mortality risk, especially from ...

A slow immune response to SARS-CoV-2 infection, delayed viral clearance, and viral rebound can all increase a person’s risk ...